As the Seattle Seahawks meet the Green Bay Packers this weekend, there won’t be a lot of positive thinking going
Russell Wilson Reveals How to Think Like a Champion
Home »
Study reveals neuroendocrine tumor mortality patterns to inform treatment decisions
Among all patients with neuroendocrine tumors (NETs), the risk of dying of cancer was higher than that of dying of
New study reveals patients from minority ethnic groups are more likely to be admitted to hospital
Patients from minority ethnic groups have a disproportionately higher rate of emergency hospital admissions, according to research by Queen Mary
Research reveals extraordinary rates of rare neuromuscular disorder in Indigenous people in Saskatchewan
Researchers at the University of Saskatchewan (USask) and University of Calgary have found unusually high rates of Spinal Bulbar Muscular
Research reveals new IgM antibodies to fight COVID-19 more potent than commonly used ones
A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective
New mapping technique reveals epigenetic drivers of cancers
Scientists have made major advances in understanding and developing treatments for many cancers by identifying genetic mutations that drive the
Study reveals crucial details on skin-related side effects of cancer immune therapies
Immune checkpoint inhibitors, which boost the immune system’s response against tumor cells, have transformed treatment for many advanced cancers, but
Case study of rare nervous system tumor reveals hypermutation
While deadly, gliosarcomas are a rare central nervous system tumor often overshadowed in research by more common tumors. These sarcomas
Ultrasound reveals the human brain vasculature down to the microscopic scale
Mapping the cerebral vascular network in human patients, at unprecedented scales: This tour de force has been achieved by the
Surface testing for SARS-CoV-2 in hematology/oncology settings reveals negligible detection
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency